Venetoclax Induces BCL-2-Dependent Treg to TH17 Plasticity to Enhance the Antitumor Efficacy of Anti-PD-1 Checkpoint Blockade.

Venetoclax Induces BCL-2-Dependent Treg to TH17 Plasticity to Enhance the Antitumor Efficacy of Anti-PD-1 Checkpoint Blockade. Cancer Immunol Res. 2024 Aug 01; 12(8):1074-1089.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Bridged Bicyclo Compounds, Heterocyclic
Cell Line, Tumor
Humans
Mice
Mice, Inbred C57BL
Programmed Cell Death 1 Receptor
Proto-Oncogene Proteins c-bcl-2
Sulfonamides
Th17 Cells
T-Lymphocytes, Regulatory
Tumor Microenvironment

authors with profiles

Andrew Koh
James L. LaBelle